資源描述：
《復(fù)方抗感顆粒制備工藝學(xué)和辨證治療風(fēng)熱型感冒臨床應(yīng)用探究》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在工程資料-天天文庫。
1、復(fù)方抗感顆粒制備工藝學(xué)和辨證治療風(fēng)熱型感冒臨床應(yīng)用探究（山東省萊蕪市人民醫(yī)院山東萊蕪271100）作者簡介：陳艷紅，女，大學(xué)本科，主管藥師，現(xiàn)在山東省萊蕪市人民醫(yī)院工作。摘要：目的探討復(fù)方抗感顆粒的制備工藝學(xué)及辨證治療風(fēng)熱型感冒的臨床應(yīng)用。方法利用先進的生產(chǎn)工藝設(shè)備，對復(fù)方抗感顆粒的制備、工藝流程及質(zhì)量控制進行研究，同時選擇2011.03?2012.03間來我院就診的感冒患者150例，均系我院門診病人。按隨機同期分組之原則，分屬顆粒劑組與傳統(tǒng)湯劑組各75例。傳統(tǒng)湯劑及顆粒劑均采用同批號、同產(chǎn)地市售藥材，根據(jù)各自的加工工藝分別制作而成。傳統(tǒng)湯劑均根據(jù)處方原配伍劑量稱取，并按常規(guī)煎藥規(guī)程煎制，
2、每日口服2次。顆粒劑則取傳統(tǒng)湯劑日量生藥，按其加工工藝制備成2袋成藥，每袋10克。每次一袋，日服2次。服用時僅需將成品沸水提泡3?5min,略加攪拌便可服用。結(jié)果經(jīng)用上述方法治療后，顆粒劑組患者痊愈67例，取得痊愈率為89.33%,顯效6例，有效2例,取得總有效率為100.00%；湯劑組患者痊愈49例，取得痊愈率為65.33%,顯效18例，有效8例，取得總有效率為100.00%。經(jīng)兩組比較，均無無效病例，總有效率無顯著性差異（P>0.05）,但臨床痊愈率比較差異明顯（△PV0.05）。結(jié)論補復(fù)方抗感顆粒的制備工藝簡便，質(zhì)量易于控制，對風(fēng)熱型感冒治療的藥理作用明確，可安全應(yīng)用于臨床，取得顯著
3、的臨床療效。關(guān)鍵詞：風(fēng)熱型感冒；復(fù)方抗感顆粒；制備工藝/質(zhì)量控制Abstract:Objectivetostudythepreparationtechnologyofcompoundantisensegranules,typewindhotcoldtheclinicalapplicationofdiagnosisandtreatment?Methodsbyusingtheadvancedproductionprocessequipment,preparationofcompoundantisenseofgrains,technologicalprocessandqualitycontrol
4、arestudied,atthesametime,choosetobetween2011.03~2012.03coldpatients150casesofourhospital,outpatientdepartmentofourhospita1.Accordingtotheprincipleofrandomgroupingperiod,belongtogranulesandthetraditionalonegroup75caseseach.Traditionaloneandgranulesaremadeandthebatchnumber,andtheoriginofmedicinalmat
5、erialsmarket,accordingtotheirrespectiveprocessingrespectively.Traditionaloneaccordingtotheprescriptioncompatibilityoftheoriginaldoseaccordingtotake,andproceduresareroutinelytisanespan-fried,oral2timesaday.Granulestaketraditionalonedaycrudedrugs,preparationaccordingtoitsprocessinginto2bagofmedicine
6、,10gramsforeachbag.Abageachtime,2timesaday.Takingonlyfinishedwhenboilingwatertosoakfor3?5min,stiralittlecanbetaken.Resultsaftertreatmentwiththeabovemethod,granulegroupofpatientsrecoveredin67cases,cureratewas89.33%,6caseshadmarkedeffect,2caseseffectively,thetotaleffectiveratewas100.00%；Onegroupofpa
7、tientsrecoveredin49cases,curerateis65.33%,18caseshadmarkedeffect,8caseseffectively,thetotaleffectiveratewas100.00%?Comparisonoftwogroups,noinvalidcases,totaleffectiveratewasnosignificantdifference(P>0.05),butobvi
